# Daisy Cai

> Daisy Cai is a General Partner at B Capital, the multi-stage venture firm co-founded by Eduardo Saverin. With nearly two decades of investment experience spanning Silicon Valley, Hong Kong, and global markets, she heads B Capital's China expansion and leads investments in deep tech, AI, robotics, autonomous systems, clean energy, and space technology. Before B Capital, she was a Partner at SoftBank Vision Fund and Managing Partner of Baidu Capital and Baidu Ventures. She holds a B.S. from Tsinghua University, an M.S. in Electrical Engineering from USC, and an MBA from Columbia Business School - and has six U.S. patents in semiconductor chip design.

- **Role:** General Partner at B Capital
- **Organizations:** B Capital, SoftBank Vision Fund, Baidu Capital, Baidu Ventures, Gaocheng Capital, TA Associates, Goldman Sachs Investment Partners, Deutsche Bank Principal Investments, Advanced Micro Devices (AMD)
- **Nationality:** Chinese-American
- **Education:** B.S. in Engineering, Tsinghua University, M.S. in Electrical Engineering, University of Southern California (USC), MBA, Columbia Business School
- **Known for:** 6 U.S. patents in semiconductor chip design from early AMD career, Led B Capital's formal expansion into China in 2021, Managed potential 40% allocation of B Capital's $1.9B global fund to China

## Career timeline

- **Early career** — Chip architect designer at Advanced Micro Devices (AMD) in Silicon Valley; earned 6 U.S. patents in semiconductor chip design
- **Mid-career** — Investment Director at Goldman Sachs Investment Partners (Hong Kong) - led TMT, consumer, and financial services deals in Greater China
- **Mid-career** — Partner at Deutsche Bank Principal Investments - growth equity and PIPE deals in Asia
- **Mid-career** — Managing Partner at TA Associates (Hong Kong) - growth capital in TMT, consumer, and education in Greater China
- **Pre-2016** — Founding Partner at Gaocheng Capital, a Hillhouse-backed growth capital firm
- **2016-2020** — Managing Partner at Baidu Capital and Baidu Ventures - managed early-stage (Ventures) and late-stage (Capital) investments; focus on AI, VR, and AR
- **2020-2021** — Partner at SoftBank Vision Fund - global technology and innovation investments
- **2021-present** — General Partner at B Capital - leads China expansion and deep tech investing in US and Asia

## Achievements

- 6 U.S. patents in semiconductor chip design from early AMD career
- Led B Capital's formal expansion into China in 2021
- Managed potential 40% allocation of B Capital's $1.9B global fund to China
- Board member at Apptronik (humanoid robotics), Knox Systems, Writer.ai, EvenUp Law, and others
- Backed GeekPlus prior to its July 2025 IPO
- Backed Profound Bio prior to its acquisition by Genmab in 2024
- Backed Insilico Medicine ahead of its December 2025 IPO
- Built investment track record across Goldman Sachs, Deutsche Bank, TA Associates, Baidu, SoftBank, and B Capital
- Nearly two decades of cross-border investment experience spanning US, Europe, and Asia

## Latest updates

- **2026-04** — Appeared on CNBC discussing why the future of software remains bright despite the rise of AI agents, describing it as a 'tech restacking' rather than a threat
- **2026-01** — Participated in 0100 Conferences deep tech panel discussing robotics, chips, and defense investment thesis
- **2025-07** — Portfolio company GeekPlus (autonomous robotics) completed IPO
- **2025-12** — Portfolio company Insilico Medicine completed IPO
- **2024** — Portfolio company Profound Bio acquired by Genmab

## Links

- Website: https://b.capital/team/daisy-cai/
- LinkedIn: https://www.linkedin.com/in/daisy-cai-0a98871/
- Twitter/X: https://twitter.com/daisy_cai
- Facebook: https://facebook.com/bcapitalgroup

---

Profile page: https://yespress.io/daisy-cai
Published by YesPress — https://yespress.io
Last updated: 2026-05-19